Multiple dose kinetics of spironolactone and canrenoate-potassium in cardiac and hepatic failure.
D000328:Adult; D000368:Aged; D002264:Carboxylic Acids / Q000097:blood; D005260:Female; D005470:Fluorometry; D006207:Half-Life; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D007664:Ketosteroids / Q000097:blood; D008103:Liver Cirrhosis / Q000378:metabolism; D008107:Liver Diseases / Q000097:blood*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D009203:Myocardial Infarction / Q000097:blood; D011245:Pregnadienes / Q000097:blood*; D013148:Spironolactone / Q000378:metabolism* / Q000652:urine; D013997:Time Factors
D002264:Carboxylic Acids; D007664:Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D011245:Pregnadienes; D013148:Spironolactone